Modulation of Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein Interactions Enhances Skeletal Muscle Regeneration and Ameliorates the Dystrophic Pathology in mdx Mice

This publication has 41 references indexed in Scilit:

• Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice
  American Journal of Physiology-Endocrinology and Metabolism, 2006
• Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury
  Gene Therapy, 2006
• Interleukin-15 Administration Improves Diaphragm Muscle Pathology and Function in Dystrophic mdx Mice
  The American Journal of Pathology, 2005
• β₂-Agonist administration increases sarcoplasmic reticulum Ca²⁺-ATPase activity in aged rat skeletal muscle
  American Journal of Physiology-Endocrinology and Metabolism, 2005
• ROLE OF CONTRACTION‐INDUCED INJURY IN THE MECHANISMS OF MUSCLE DAMAGE IN MUSCULAR DYSTROPHY
  Clinical and Experimental Pharmacology and Physiology, 2004
• Administration of insulin‐like growth factor‐I improves fatigue resistance of skeletal muscles from dystrophic mdx mice
  Muscle & Nerve, 2004
• Insulin-like growth factor 1 and muscle growth: implication for satellite cell proliferation
  Proceedings of the Nutrition Society, 2004
• The muscular dystrophies
  Published by Elsevier ,2002
• Identification of a Nonpeptide Ligand That Releases Bioactive Insulin-like Growth Factor-I from Its Binding Protein Complex
  Journal of Biological Chemistry, 2001
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976